Fibroblast growth factor 18 (FGF18) is a member of the fibroblast growth factor family (FGFs).
FGF18 is a class of bioactive substances that can conduct biological signals, regulate cell …

Background Detection of appropriate receptor proteins and drug agents are equally
important in the case of drug discovery and development for any disease. In this study, an …

Background Necroptosis, is intimately linked to tumor development and prognosis and has
been considered as a target for anticancer therapy. However, the role of necroptosis-related …

Si Jun Zi Tang (SJZT) is a classic Traditional Chinese Medicine (TCM) prescription used to
treat aging-related diseases. However, the potential molecular mechanisms of the anti-aging …

Background Stage IV colorectal cancer patients with liver metastasis represent a special
group of CRC patients with poor prognosis. The prognostic factors have not been …

Background: Currently, there are no useful biomarkers or prognostic risk markers for the
diagnosis of kidney renal clear cell carcinoma (KIRC), although recent research has shown …

Immune-modulating therapies exhibit abundant promise compared to traditional treatment
for osteosarcoma. We aim to establish an immune-related prognostic signatures in …

Senescence-induced therapy was previously considered as an effective treatment for
tumors, and cellular senescence was initially regarded as an effective mechanism against …

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality, and
prognosis assessment is crucial for guiding treatment decisions. In this study, we aimed to …

2021-06-23 Assigned to BRISTOL-MYERS SQUIBB COMPANY reassignment BRISTOL-
MYERS SQUIBB COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …